Clinical Trial Update: An Efficacy and Safety Study of Sevelamer Carbonate in Hyperphosphatemic Pediatric Participants With Chronic Kidney Disease [Phase 2]

View source ↗

Summary

This document summarizes a Phase 2 efficacy and safety study of sevelamer carbonate in hyperphosphatemic pediatric participants with chronic kidney disease. Res…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Hyperphosphatemia

Drugs mentioned

• SEVELAMER CARBONATE (sevelamer carbonate)

Snippet

Sponsor: Genzyme, a Sanofi Company | Conditions: Hyperphosphatemia, Chronic Kidney Disease | Phase 2 | Status: COMPLETED | Results posted: 2016-07-25